🎁 Black Friday: up to 50% off of annual plans
Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.050
-0.020 (-1.87%)
Nov 20, 2026, 4:00 PM EST - Market closed

Actinium Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10.6-33.89-38.24-48.82-33.02-24.77
Depreciation & Amortization
0.890.820.810.790.70.52
Stock-Based Compensation
0.289.195.293.842.81.69
Change in Accounts Payable
0.41-0.35-0.39-2.184.61.2
Change in Unearned Revenue
-35---341
Change in Other Net Operating Assets
-0.52-0.36-0.55-0.97-0.43-0.5
Operating Cash Flow
-23.36-24.58-33.07-47.348.64-20.87
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.35-0.1-0.01-0.15-0.37-0.13
Investing Cash Flow
-1.35-0.1-0.01-0.15-0.37-0.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.01-0.01-0-0.05-0.09
Total Debt Repaid
-0.01-0.01-0.01-0-0.05-0.09
Net Debt Issued (Repaid)
-0.01-0.01-0.01-0-0.05-0.09
Issuance of Common Stock
--29.3314.8723.1635.31
Repurchase of Common Stock
--0.21----
Financing Cash Flow
-0.01-0.2229.3214.8723.1135.22

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.020.01----
Net Cash Flow
-24.71-24.9-3.76-32.6231.3914.22

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-24.72-24.68-33.08-47.498.28-21
Free Cash Flow Growth
------
Free Cash Flow Margin
-70.61%-27426.67%--58627.16%803.69%-1835.58%
Free Cash Flow Per Share
-0.79-0.79-1.10-1.780.34-1.02
Levered Free Cash Flow
14.52-12.85-20.63-29.7-14.7-11.88
Unlevered Free Cash Flow
15.08-12.85-20.63-29.7-14.7-11.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-35.12-0.7-0.93-3.1538.171.69
SEC Filings: 10-K · 10-Q